Abstract
This article evaluates the clinical relevance of ultrasonography during pregnancy complicated by diabetes for fetal surveillance, assessment of diabetes impact, guidance of diabetes treatment, and obstetric management. Although ultrasound has improved, its effect on reduction of perinatal morbidity and mortality remains to be proven, and its use to detect large-for-gestational-age fetuses is unreliable. Clinical decisions based on birth weight prediction by sonography are often in error. Measurement of the insulin-sensitive fetal fat layer and fetal abdominal circumference may better reflect the impact of diabetes on the fetus.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
